Pharmaceuticals News

Agomab today announced the launch of its initial public offering of 12,500,000 ADSs pursuant to a registration statement filed with the SEC.

GÖTTINGEN, Allemagne, 02 févr. 2026 (GLOBE NEWSWIRE) -- La société de biotechnologie allemande Repairon GmbH a annoncé la création de sa filiale à 100 %, Repairon USA, Inc., afin de...

GÖTTINGEN, Deutschland, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Das deutsche Biotech-Unternehmen Repairon GmbH hat die Bildung seiner hundertprozentigen Tochtergesellschaft Repairon USA, Inc....

Mount Sinai and BPGbio scientists uncover novel molecular drivers from live brain samples that direct human brain structure and function from early development through aging: Creates a completely new...

22.3% total weight loss at 52 weeks with nimacimab (200 mg dose) + semaglutide (2.4 mg) combination — no plateau observed, suggesting potential for further efficacy beyond one year and at higher...

NEEDHAM, Mass., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Bioxytran, Inc. (OTCQB: BIXT) (“Bioxytran” or the “Company”), a clinical-stage biotechnology company developing platform technologies spanning...

SAN MATEO, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional...

TARRYTOWN, N.Y., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced upcoming presentations from its ophthalmology portfolio and pipeline at the virtual...

Deficiencies limited to packaging and administrationCompany believes it can rapidly resolve deficiencies and expects to resubmit as early as Q3 2026Remains well-capitalized and anticipates ending 2026...

Doubling of VEVYE® Sales Force is On Track, Expansion of IHEEZO® Commercial Footprint to the Office-Based Setting Underway, and Doubling TRIESENCE® Commercial Footprint in the Surgical-Based Setting...